Trial intelligence / Profile preview

Anti-inflammatory effect of platelet-rich plasma compared with intraarticular corticosteroid in knee osteoarthritis

TCTR20240728001Phase 3Completed

Sponsor
Phramongkutklao Hospital
Start
Dec 2022
Countries
1
01

Overview

Phase 3, randomised trial of platelet-rich plasma in osteoarthritis (OA) (2 arms), sponsored by Phramongkutklao Hospital. Started Dec 2022; status: completed.

02

Drugs

platelet-rich plasma
03

Conditions

osteoarthritis (OA)

Beyond the preview

Go deeper on TCTR20240728001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20240728001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call